Total Payments
$606.79
2024 Payments
$109.01
Companies
5
Transactions
6
Medicare Patients
6,382
Medicare Billing
$328,542
Payment Breakdown by Category
Food & Beverage$606.79 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $606.79 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $145.83 | 1 | $0 (2021) |
| Blueprint Medicines Corporation | $139.81 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $127.36 | 1 | $0 (2021) |
| Life Technologies Corporation | $99.98 | 1 | $0 (2018) |
| Myriad Genetic Laboratories, Inc. | $93.81 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.01 | 1 | Blueprint Medicines Corporation ($109.01) |
| 2022 | $30.80 | 1 | Blueprint Medicines Corporation ($30.80) |
| 2021 | $367.00 | 3 | Adaptive Biotechnologies Corporation ($145.83) |
| 2018 | $99.98 | 1 | Life Technologies Corporation ($99.98) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2024 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $109.01 | General |
| 09/12/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/22/2021 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $145.83 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 12/08/2021 | Myriad Genetic Laboratories, Inc. | myChoice CDx (Device) | Food and Beverage | Cash or cash equivalent | $93.81 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $127.36 | General |
| Category: Oncology | ||||||
| 12/19/2018 | Life Technologies Corporation | LSG - GSD - Clinical - Molecular Diagnostics (Device) | Food and Beverage | Cash or cash equivalent | $99.98 | General |
| Category: Anatomic Pathology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,629 | 3,236 | $764,990 | $91,740 |
| 2022 | 23 | 1,725 | 3,118 | $772,215 | $89,479 |
| 2021 | 22 | 1,415 | 2,286 | $601,875 | $67,143 |
| 2020 | 22 | 1,613 | 2,686 | $683,480 | $80,181 |
Total Patients
6,382
Total Services
11,326
Medicare Billing
$328,542
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 155 | 875 | $131,250 | $18,686 | 14.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 273 | 506 | $202,400 | $14,175 | 7.0% |
| 88374 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | Facility | 2023 | 83 | 393 | $39,300 | $12,161 | 30.9% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 104 | 120 | $45,000 | $7,646 | 17.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 75 | 112 | $58,800 | $6,970 | 11.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 182 | 224 | $72,800 | $5,872 | 8.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 129 | 178 | $53,400 | $5,552 | 10.4% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Facility | 2023 | 39 | 85 | $11,475 | $3,846 | 33.5% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 78 | 86 | $22,360 | $3,099 | 13.9% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 35 | 51 | $18,615 | $2,392 | 12.9% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 62 | 68 | $17,000 | $2,198 | 12.9% |
| 88364 | Genetic sequencing localization, each additional procedure | Facility | 2023 | 36 | 51 | $12,240 | $1,319 | 10.8% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 115 | 135 | $19,575 | $1,252 | 6.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 34 | 61 | $8,845 | $1,226 | 13.9% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 11 | 11 | $7,700 | $1,205 | 15.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 80 | 131 | $20,960 | $1,184 | 5.6% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 19 | 21 | $7,665 | $951.22 | 12.4% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 38 | 43 | $3,655 | $776.02 | 21.2% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 38 | 42 | $4,200 | $620.76 | 14.8% |
| 88381 | Preparation of specimen, manual | Facility | 2023 | 17 | 17 | $2,550 | $384.03 | 15.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 26 | 26 | $5,200 | $222.82 | 4.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 142 | 743 | $111,450 | $15,998 | 14.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 323 | 542 | $216,800 | $15,562 | 7.2% |
| 88374 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | Facility | 2022 | 84 | 378 | $50,900 | $12,245 | 24.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 80 | 118 | $61,950 | $7,526 | 12.1% |
About Dr. Alan Brown, MD
Dr. Alan Brown, MD is a Molecular Genetic Pathology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1841587771.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Brown, MD has received a total of $606.79 in payments from pharmaceutical and medical device companies, with $109.01 received in 2024. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($606.79).
As a Medicare-enrolled provider, Brown has provided services to 6,382 Medicare beneficiaries, totaling 11,326 services with total Medicare billing of $328,542. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Molecular Genetic Pathology
- Other Specialties Student in an Organized Health Care Education/Training Program, Anatomic Pathology & Clinical Pathology
- Location San Antonio, TX
- Active Since 06/29/2011
- Last Updated 01/23/2023
- Taxonomy Code 207ZP0007X
- Entity Type Individual
- NPI Number 1841587771
Products in Payments
- clonoSEQ (Device) $145.83
- LYNPARZA (Drug) $127.36
- LSG - GSD - Clinical - Molecular Diagnostics (Device) $99.98
- myChoice CDx (Device) $93.81
- AYVAKIT (Drug) $30.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.